Chemistry:2C-EF

From HandWiki

2C-EF, also known as 4-(2-fluoroethyl)-2,5-dimethoxyphenethylamine, is a psychedelic drug of the phenethylamine and 2C families.[1][2] It is the 2C analogue of the DOx psychedelic DOEF.[1] The drug is taken orally.[2] 2C-EF was first described in the literature in 1991.[1]

Use and effects

2C-EF is an active psychedelic drug and has a dose range of 6 to 12 mg orally and duration of 12 hours.[2]

Interactions

2C-EF is metabolized by monoamine oxidase (MAO) enzymes, including monoamine oxidase A (MAO-A) and/or monoamine oxidase B (MAO-B).[3] Monoamine oxidase inhibitors (MAOIs) such as phenelzine, tranylcypromine, moclobemide, and selegiline may potentiate the effects of 2C-EF.[3][4] This may result in overdose and serious toxicity.[3][4]

Pharmacology

Pharmacodynamics

2C-EF is a serotonergic psychedelic.[2]

Pharmacokinetics

The metabolism of 2C-EF has been studied in vitro.[3] It undergoes demethylation at position 2 or 5, hydroxylation, and deamination, as well as acetylation and glucuronidation.[3] Oxidative deamination, mediated mainly by monoamine oxidase (MAO) enzymes, is the main route of metabolism for 2C-EF.[3]

Chemistry

Analogues

A notable derivative of 2C-EF is 2C-EF-FLY.[5][6]

History

2C-EF was originally named by Alexander Shulgin in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved).[1] However, he only speculated about it and never actually synthesized or tested it himself.[1] Subsequently, 2C-EF was synthesized and tested by others such as Daniel Trachsel.[7][8]: 770 

See also

References

  1. 1.0 1.1 1.2 1.3 1.4 Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628. http://www.erowid.org/library/books_online/pihkal/pihkal.shtml.  "DOEF". https://erowid.org/library/books_online/pihkal/pihkal065.shtml. "And I’ll bet you dollars to doughnuts, that if one were to make the two-carbon analog 2,5-dimethoxy-4-(2-fluoroethyl)phenethylamine, it would be every bit as much a treasure and ally as is 2C-B or 2C-I. In fact, I am sure enough about this prediction that I am willing to name the stuff 2C-EF. It will be easily made from 2C-B by the same reaction scheme that was used above for DOEF. And I will even guess that its activity level will be in the 20–30 milligram area." 
  2. 2.0 2.1 2.2 2.3 "Comparison of the behavioral responses induced by phenylalkylamine hallucinogens and their tetrahydrobenzodifuran ("FLY") and benzodifuran ("DragonFLY") analogs". Neuropharmacology 144: 368–376. January 2019. doi:10.1016/j.neuropharm.2018.10.037. PMID 30385253. "According to Shulgin and Shulgin (1991), 2C-E is active at doses of 10–25 mg. 4-(2-Fluoroethyl)-2,5-dimethoxyphenethylamine (2C-EF) also reportedly acts as a hallucinogen and is orally active in humans at doses of 6–12 mg with a duration of 12 hours (Shulgin et al. 2011), although information about the extent of recreational use of this substance appears to be lacking.". 
  3. 3.0 3.1 3.2 3.3 3.4 3.5 "Metabolic profiling of 2C-EF in human liver microsomes: Identification of major metabolites and biotransformation pathways". Toxicologie Analytique et Clinique. 2025. doi:10.1016/j.toxac.2025.08.005. 
  4. 4.0 4.1 "Drug-drug interactions involving classic psychedelics: A systematic review". Journal of Psychopharmacology 38 (1): 3–18. January 2024. doi:10.1177/02698811231211219. PMID 37982394. 
  5. "Phenethylamine-derived new psychoactive substances 2C-E-FLY, 2C-EF-FLY, and 2C-T-7-FLY: Investigations on their metabolic fate including isoenzyme activities and their toxicological detectability in urine screenings". Drug Testing and Analysis 11 (10): 1507–1521. October 2019. doi:10.1002/dta.2675. PMID 31299701. 
  6. "How preclinical studies have influenced novel psychoactive substance legislation in the UK and Europe". British Journal of Clinical Pharmacology 86 (3): 452–481. March 2020. doi:10.1111/bcp.14224. PMID 32045495. 
  7. "The frontier orbital phase angles: novel QSAR descriptors for benzene derivatives, applied to phenylalkylamine hallucinogens". Journal of Medicinal Chemistry 41 (20): 3845–3856. September 1998. doi:10.1021/jm980144c. PMID 9748359. 
  8. Phenethylamine: Von der Struktur zur Funktion. Nachtschatten Verlag AG. 2013. ISBN 978-3-03788-700-4.